Cargando…
Male DCIS diagnosed after use of over-the-counter hormonal supplement
INTRODUCTION: Male breast cancer is a rare disease. Although epidemiologic and genetic factors are associated with male breast cancer, hormonal factors may also play a role. CASE PRESENTATION: We report the case of a 39-year-old BRCA negative male patient taking a sexual performance enhancement supp...
Autores principales: | Agbroko, S.O., Rojas, K.E., Manasseh, D.M., Borgen, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430715/ https://www.ncbi.nlm.nih.gov/pubmed/30903856 http://dx.doi.org/10.1016/j.ijscr.2019.02.028 |
Ejemplares similares
-
A spontaneous unveiling of bilateral DCIS in an elderly male
por: Meyer, Tessa, et al.
Publicado: (2020) -
Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016) -
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
por: Wallis, M G, et al.
Publicado: (2012) -
Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022) -
Vitamin D Supplements: Over-the-Counter Accessibility... It Is Safe?
por: Figueroa-Cruz, Alegyari, et al.
Publicado: (2021)